rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    PRCT
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Truist Financial Keeps Their Hold Rating on PROCEPT BioRobotics (PRCT)

      Tipranks Press Release.

      Nov 7The Globe and MailPRCTTFC
      Procept BioRobotics chief strat/marketing officer sells $92,852 in stock
      Nov 6Investing.comPRCT
      PROCEPT BioRobotics (PRCT) Stock Dropped, So What Is Driving Attention Now?

      PROCEPT BioRobotics (PRCT) is back in focus after reporting third quarter 2026 results that paired 18% year-over-year revenue growth with a wider net loss, while management held firm on full year guidance. Investors have reacted cautiously to the latest update, with the 1-day share price return declining 6.4% to leave PROCEPT BioRobotics at US$20.27. That move sits against a 30-day share price gain of 15.8%, a year-to-date share price decline of 34.1%, and a 1-year total shareholder return...

      Nov 6Yahoo FinancePRCT
      PROCEPT BioRobotics Corporation Q3 2026 Earnings Call Summary
      Nov 5Yahoo FinancePRCT
      PROCEPT BioRobotics Corp (PRCT) (Q3 2026) Earnings Call Highlights: Revenue Grows 18% as Hydros ...
      Nov 5Yahoo FinancePRCT
      PROCEPT BioRobotics Q3 Earnings Call Highlights
      Nov 5Yahoo FinancePRCT
      PROCEPT BioRobotics Corporation (PRCT) Reports Q3 Loss, Lags Revenue Estimates

      PROCEPT BIOROBO (PRCT) delivered earnings and revenue surprises of -17.95% and -1.78%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

      Nov 4Yahoo FinancePRCT
      PROCEPT BioRobotics Q3 2026 Earnings Call Transcript
      Nov 4BenzingaPRCT
      Procept Biorobotics earnings missed by $0.07, revenue fell short of estimates
      Nov 4Investing.comPRCT
      PROCEPT BioRobotics Reports Third Quarter 2026 Financial Results and Reaffirms 2026 Financial Guidance
      Nov 4Yahoo FinancePRCT
      Procept Biorobotics earnings on deck amid lawsuit, competition
      Nov 4Investing.comPRCT
      Earnings To Watch: PROCEPT BioRobotics Corp (PRCT) Q3 2026 -- GF Value Sees 471% Upside
      Nov 3Yahoo FinancePRCT
      PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

      PROCEPT BIOROBO (PRCT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

      Oct 28Yahoo FinancePRCT
      PROCEPT BioRobotics (PRCT) Stock May Be Fully Priced On Cash Flow Hopes
      Oct 25Yahoo FinancePRCT
      PROCEPT BioRobotics Stock: Compelling Bet On Aquablation’s Growth (NASDAQ:PRCT)

      PROCEPT BioRobotics’ Aquablation may ease BPH symptoms while preserving function. Read here for a detailed investment analysis of PRCT stock.

      Oct 23Seeking AlphaPRCT
      PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

      SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the “Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced it will report financial results for the third quarter of 2026 after market close on Wednesday, November 4, 2026. The Company’s management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to

      Oct 12Yahoo FinancePRCT
      PROCEPT BioRobotics (PRCT) Could Be 70% Undervalued On Lawsuit And Board Change

      Why this governance shift at PROCEPT BioRobotics matters for investors A fresh investor lawsuit and the appointment of cardiac surgeon Dr. Michael Mack to the board put PROCEPT BioRobotics (PRCT) under a governance spotlight that stockholders will want to understand closely. Recent trading tells a story of pressure rather than momentum for PROCEPT BioRobotics, with the share price delivering a 30 day return of down 21.31% and a year to date share price return of down 41.77%. The 1 year total...

      Oct 8Yahoo FinancePRCT
      Does New Director and Discounting Lawsuit Change The Bull Case For PROCEPT BioRobotics (PRCT)?

      In early October 2026, PROCEPT BioRobotics added veteran cardiac surgeon Dr. Michael Mack to its board as an independent Class II director, while also facing a newly filed securities lawsuit alleging undisclosed discounting practices that inflated reported U.S. handpiece demand and related operational risks. The combination of a medically seasoned, research-focused director and allegations about bulk-order discounting practices raises important questions about PROCEPT’s governance,...

      Oct 6Yahoo FinancePRCT
      PROCEPT BioRobotics Extends Term Loan Maturity Agreement

      Detailed price information for Procept Biorobotics Corp (PRCT-Q) from The Globe and Mail including charting and trades.

      Sep 25The Globe and MailPRCT
      Procept BioRobotics extends loan maturity date with CIBC by one year
      Sep 24Investing.comPRCTCM
      Kaplan Fox Continues to Alert Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to a Class Action Deadline on September 22, 2026

      Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailPRCT
      Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026

      Detailed price information for Procept Biorobotics Corp (PRCT-Q) from The Globe and Mail including charting and trades.

      Sep 22The Globe and MailPRCT
      PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit
      Sep 21MorningstarPRCT
      Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026

      Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.

      Sep 21The Globe and MailPRCT
      Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 22, 2026

      Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.

      Sep 18The Globe and MailPRCT
      Kaplan Fox Reminds Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to a Securities Class Action Deadline - Contact the Firm Before September 22, 2026
      Sep 17BarchartPRCT
      SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026 - PRCT
      Sep 17MorningstarPRCT
      Planet 13 Announces Q2 2021 Financial Results

      Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.

      Sep 15The Globe and MailPRCT
      Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) is September 22, 2026

      Detailed price information for Procept Biorobotics Corp (PRCT-Q) from The Globe and Mail including charting and trades.

      Sep 15The Globe and MailPRCT
      PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
      Sep 15MorningstarPRCT
      Kaplan Fox Announces a Securities Class Action Filed Against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) - Lead Plaintiff Deadline is September 22, 2026

      Detailed price information for Procept Biorobotics Corp (PRCT-Q) from The Globe and Mail including charting and trades.

      Sep 15The Globe and MailPRCT
      LAWSUIT NOTICE: NASDAQ: PRCT Investors who lost money with PROCEPT BioRobotics Corporation shares should contact the Shareholders Foundation
      Sep 15MorningstarPRCT
      Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Contact the Firm Before the Deadline on September 22, 2026

      Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.

      Sep 14The Globe and MailPRCT
      Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm Before Lead Plaintiff Deadline on September 22, 2026
      Sep 11BarchartPRCT
      PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
      Sep 11MorningstarPRCT
      Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights
      Sep 10BarchartPRCT
      Procept BioRobotics EVP Alaleh Nouri sells $6,223 in PRCT stock
      Sep 10Investing.comPRCT
      PRCT Deadline Alert: SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION (PRCT) Investors of Securities Class Action Deadline on September 22, 2026
      Sep 10MorningstarPRCT
      Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to Contact the Firm Before September 22, 2026
      Sep 9BarchartPRCT
      PRCT UPCOMING DEADLINE: Levi & Korsinsky Alerts PROCEPT BIOROBOTICS CORPORATION Stockholders of Securities Class Action - Contact the Firm
      Sep 9MorningstarPRCT
      Oppenheimer reiterates Procept BioRobotics stock rating
      Sep 9Investing.comPRCT
      Kaplan Fox Alerts PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors to Seek Leadership in a Securities Fraud Lawsuit by September 22, 2026
      Sep 8BarchartPRCT
      PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit
      Sep 5MorningstarPRCT
      Kaplan Fox Deadline Alert: PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Have Until September 22, 2026 to Seek a Lead Plaintiff Role
      Sep 4BarchartPRCT
      PROCEPT BioRobotics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against PROCEPT BioRobotics Corporation - PRCT
      Sep 4MorningstarPRCT
      Kaplan Fox Continues to Remind PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors of the Lead Plaintiff Deadline on September 22, 2026

      Detailed price information for Bank of America Corp (BAC-N) from The Globe and Mail including charting and trades.

      Sep 3The Globe and MailPRCT
      PRCT Shareholder Alert: PROCEPT BIOROBOTICS CORPORATION Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt
      Sep 3MorningstarPRCT
      PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

      Detailed price information for Procept Biorobotics Corp (PRCT-Q) from The Globe and Mail including charting and trades.

      Sep 3The Globe and MailPRCT
      Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2026 in PROCEPT BIOROBOTICS CORPORATION Lawsuit - PRCT
      Sep 2MorningstarPRCT
      PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
      Sep 2BarchartPRCT

      This is the newest page. Registered accounts read further back.